Skip to main content

Camena Bioscience Announces Executive Leadership Update

Camena Bioscience Announces Executive Leadership Update
1 minute read

Download press release


Cambridge, UK, 12 November 2026: 

Camena Bioscience Limited announced today that Dr Steve Harvey, co-founder of the company, will be leaving on Friday 13 November 2026.

Since co-founding the company, Steve has been instrumental in transitioning Camena from a conceptual start-up into a DNA synthesis firm.

He directly co-developed Camena’s patented DNA synthesis technology, a pioneer in enzymatic DNA synthesis producing complex, high-fidelity gene constructs for AI-driven antibody discovery, to solve the limitations of accuracy, speed and scale.

Greg McGuinness, CEO, Camena Bioscience commented:
“On behalf of the board and I, we would like to thank Steve for his contribution to Camena and wish him every success for the future”.

Caption: Camena Bioscience first tenant at the new Sidney Sussex building at Chesterford Research Park 

Share this article

Check out other articles